BioMar Group Raises Full‑Year Guidance and Adjusts Financial Calendar
The Danish aquaculture‑feed producer BioMar Group A/S has announced a revision to its 2026 financial outlook, lifting both revenue and earnings expectations. The update, disclosed on 12 August 2026, follows a broader corporate restructuring that also includes a change to the company’s fiscal calendar.
Updated Guidance
According to the company’s press release and accompanying documents, the new revenue range for the 2026 accounting year is Danish krone (DKK) 17 – 18 billion, an upward revision from the previously forecast DKK 16 – 17 billion. Earnings before interest, tax, depreciation and amortisation (EBIT) are now expected to fall between DKK 1.2 – 1.3 billion, compared with the earlier DKK 1.1 – 1.2 billion band. These adjustments were reported in several outlets, including Globenewswire and Nasdaq OMX Nordic.
The revised targets reflect BioMar’s optimism regarding market conditions in the aquaculture sector, particularly for its core products—fish feed for salmon and shrimp. The company noted that these figures will be fully consolidated into the financial statements of its parent, Aktieselskabet Schouw & Co., whose management will subsequently integrate the updated guidance into the group’s overall 2026 forecast.
Market Reaction
Investors have responded positively to the upgrade. The Danish brokerage Danske Bank lifted its target price for BioMar Group to DKK 144 (from DKK 140) and reiterated a buy recommendation. The increase aligns with the broader trend of institutional support for the company, as seen in the coverage by Avanza and Schouw & Co. analysts.
Calendar Change
On the same day, BioMar announced a change to its financial calendar, effective from 1 January 2027. While details of the new reporting schedule were not disclosed in full, the adjustment is intended to streamline the company’s reporting cycle and better align it with its global operations.
Contextualizing the Guidance
BioMar’s share price has fluctuated throughout the year, closing at DKK 113.5 on 10 August 2026. The 52‑week high and low for the period were DKK 119.8 and DKK 102, respectively, indicating a modest upside potential. With a market cap of approximately DKK 11.4 billion, the company trades at a price‑earnings ratio of 0.02, underscoring its focus on growth rather than immediate profitability.
The upgraded guidance, coupled with a stable share price and supportive analyst coverage, positions BioMar favorably within the consumer staples sector. Its global footprint in aquaculture feed production and the continuing expansion of fish farming in emerging markets provide a solid foundation for the revised financial outlook.
